Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
  • 11/27/2024Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
  • 11/25/2024China's Real-World Data Pilot Drives Global Collaboration and Regulato...
  • 11/25/2024Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
  • 11/25/2024Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...
  • 11/21/2024China Strengthens Focus on Gene and Cell Therapy Research in Suzhou
  • 11/21/2024Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
  • 11/20/2024China-U.S. Health Experts Convene in Beijing to Address Cancer and Chr...
  • 11/19/2024China Grants Priority Review to Ascentage Pharma's Lisaftoclax NDA
  • 11/18/2024ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
  • 11/18/2024FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...
  • 11/18/2024Rona Therapeutics Unveils Promising Phase 1 Results for RNA-Based Chol...
  • 11/18/2024Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...
  • 11/14/2024Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...
  • 11/13/2024Novartis Files NDA of Pluvicto (Lu 177 vipivotide tetraxetan) in China
  • 11/13/2024NMPA Accepts CANbridge Pharma's NDA of CAN103 for Gaucher Disease
  • 11/12/2024Eccogene Secures Dual IND Approvals for Once-Daily Oral GLP-1 Receptor...
  • 11/12/2024CStone Presents Promising Preclinical Data for Trispecific Antibody CS...
  • 11/12/2024Abbisco Reports Positive Top-line Results from Pivotal Phase 3 MANEUVE...
  • 11/11/2024Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC Tre...
  • 11/11/2024China Approves Second KRAS-G12C Inhibitor, Garsorasib, Co-developed by...
  • 11/11/2024Precision Bio's CD19-Targeted CAR-T Therapy, pCAR-19B, Selected for Or...
  • 11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...
  • 11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...
  • 11/8/2024Takeda Initiates Phase 3 Trials in China for Sleep Disorder Drug TAK-8...
  • 11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...
  • 11/7/2024AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designation...
  • 11/7/2024CStone Announces Patent Publication for First-in-Class ADC CS5006
  • 11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
  • Page:8/12 Total number of articles:340: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group